Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.13 is 63% above its 3-year average of -5.72, near the high end of its 3-year range (-9.10–-2.13).
37.63% above its 12-month average of -3.42.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.43.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 21 comparable quarters.
EARNINGS PER SHARE (EPS)
-2.13
EARNINGS PER SHARE (EPS) AVG TTM
-3.42
EARNINGS PER SHARE (EPS) AVG 3Y
-5.72
EARNINGS PER SHARE (EPS) AVG 5Y
-5.72
EARNINGS PER SHARE (EPS) AVG 10Y
-5.94
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+37.63%
CURRENT VS 3Y AVG
+62.78%
CURRENT VS 5Y AVG
+62.78%
CURRENT VS 10Y AVG
+64.12%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Elicio Therapeutics, Inc.
Market Cap
$36.23M
Earnings Per Share (EPS)
-2.13
TTM Avg
-3.42
3Y Avg
-5.72
5Y Avg
-5.72
Market Cap
$35.76M
Earnings Per Share (EPS)
-1.96
TTM Avg
-0.82
3Y Avg
-0.31
5Y Avg
-0.18
Market Cap
$36.63M
Earnings Per Share (EPS)
-1.17
TTM Avg
-1.36
3Y Avg
-0.92
5Y Avg
-0.84
Market Cap
$35.62M
Earnings Per Share (EPS)
-13.84
TTM Avg
-117.78
3Y Avg
-126.66
5Y Avg
-275.31
Market Cap
$35.42M
Earnings Per Share (EPS)
0.94
TTM Avg
-0.29
3Y Avg
-1.25
5Y Avg
-1.59
Market Cap
$36.99M
Earnings Per Share (EPS)
-1.69
TTM Avg
-1.60
3Y Avg
-3.62
5Y Avg
-4.57
Market Cap
$34.58M
Earnings Per Share (EPS)
-1.26
TTM Avg
-0.80
3Y Avg
-2.79
5Y Avg
-3.86
Market Cap
$34.56M
Earnings Per Share (EPS)
-0.40
TTM Avg
-0.21
3Y Avg
-0.17
5Y Avg
-0.13
Market Cap
$38.00M
Earnings Per Share (EPS)
N/A
TTM Avg
-21.23
3Y Avg
-13.85
5Y Avg
-9.58
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | $36.23M | -2.13 | -3.42 | -5.72 | -5.72 |
| DocGo Inc. (DCGO)vs › | $35.76M | -1.96 | -0.82 | -0.31 | -0.18 |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.63M | -1.17 | -1.36 | -0.92 | -0.84 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.62M | -13.84 | -117.78 | -126.66 | -275.31 |
| Elutia Inc (ELUT)vs › | $35.42M | 0.94 | -0.29 | -1.25 | -1.59 |
| Edesa Biotech, Inc. (EDSA)vs › | $36.99M | -1.69 | -1.60 | -3.62 | -4.57 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.58M | -1.26 | -0.80 | -2.79 | -3.86 |
| Accuray Incorporated (ARAY)vs › | $34.56M | -0.40 | -0.21 | -0.17 | -0.13 |
| Incannex Healthcare Limited (IXHL)vs › | $38.00M | N/A | -21.23 | -13.85 | -9.58 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.93M | -7.30 | -11.70 | -7.29 | -5.93 |
Trailing EPS (TTM)
$-2.13
Forward EPS (Est.)
$-1.88
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.58 |
| 2024-12-31 | -4.25 |
| 2023-12-31 | -6.96 |
| 2022-12-31 | -9.10 |
| 2018-12-31 | -6.79 |
| 2013-12-31 | 103.31 |
| 2012-12-31 | 50.21 |
